Approved Study Database

Ref. No. Scientific Title Principal investigator
2006.025 A 3-year, Double-blind Extension to CZOL446H2301 to Evaluate the Long Term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D Prof. Leung Ping Chung
2006.024 A Phase I Trial of 5-Azacitidine and Suberoylanilide Hydroxamic Acid in Patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma Prof. CHAN Anthony T. C.
2006.023 Efficacy and Safety of Agomelatine With Flexible Dose (25mg/day with Potential Adjustment At 50 mg) Given Orally For 8 Weeks in Out-Patients With Major Depressive Disorder Prof. Wing Yun Kwok
2006.022 A Study on the Clinical Application of Asthma Control Test Dr. Ko Wai San Fanny
2006.021 Effect of Theophylline to Prevent Contrast Induced Nephropathy in Patients With Renal Insufficiency Dr. Fung Wing Hong Jeffrey
2006.018 Single- and Multiple-dose, Safety, Tolerability and Pharmacokinetic Study of Oral Rivoglitazone(CS-011) in Healthy Chinese Male and Female Subjects Prof. Brian Tomlinson
2006.017 Effect of Vardenafil on Blood Pressure in Patients with Erectile Dysfunction Who Received Concomitant Doxazosin GITS for The Treatment of Benign Prostatic Hyperplasia Dr. Ng Chi Fai
2006.016 A Randomized, Double-blind, Parallel Group, Placebo-controlled (With Open-label Active Comparator Arm), Dose-Ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of RO0728804 (dual PPAR Prof. Kong P.S. Alice
2006.013 Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients with Clustering Risk Factors Dr. Chow C.C. Francis
2006.012 A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50 mg Oral Dosing with the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis (NKT102553) Prof. Gin Tony
2006.009 International, Randomized, Open-label, Phase 3 Trial of Gemcitabine/ Cisplatin Plus PF-3512676 Versus Gemcitabine/Cisplatin Alone as First-line Treatment of Patients with Advanced Non-small Cell Lung Cancer Prof. Mok Tony
2006.008 A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis (NKT102552) Prof. Gin Tony
2005.473 A Randomized Control Trial of A Brain Preservation Diet in Preventing Cognitive Decline in Old Age Hostel Residents Prof. Kwok Timothy
2005.471 Infliximab Induction Therapy for Moderate-to Severe Plaque-Type Psoriasis: An Open-Label, Single Arm Observational Study Evaluating the Efficacy of Use In Hong Kong Chinese Patients Prof. LUK Tommy Nai Ming
2005.462 A Randomized, Double-blind, Placebo-controlled Study on Treatment of Nocturia with Desmopressin in Women Prof. Chan Shing Chee Symphorosa
2005.457 Changes of Cerebral Perfusion after EECP on Healthy Volunteers Prof. Wong Ka Sing Lawrence
2005.456 Phase I Study on the Study and Pharmacokinetics of Single and Repeated Application of IMD-0354 in Health Male Volunteers Prof. Brian Tomlinson
2005.455 Clinical Bioequivalence Study on Two Diazepam Formulations Prof. Chow S.S. Moses
2005.445 Open Label Extension Study Evaluating the Long Term Safety, Tolerability and Efficacy of An Iron Maintenance Dosing Strategy Utilizing Intravenous VIT-45 in the Treatment of Anemia in Non-Dialysis Dependent (NDD) Chronic Kidney Disease (CKD) Prof. Szeto Cheuk Chun
2005.444 Comparison of the Safety and Efficacy of A Unique Intravenous Iron Preparation (VIT-45) Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Prof. Szeto Cheuk Chun
2005.442 Optimal Time of Laparoscopic Cholecystectomy After Endoscopic Clearance of Endoscopic Bile Duct Stone Removal in Acute Cholangitis Prof. NG Kwok Wai
2005.427 Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study to Compare Celecoxib (200mg BID) with Diclofenac SR (75mg BID) Plus Omeprazole (20mg QD) for Gastrointestinal Events in Subjects with Osteoarthritis and Rheumatoid Arthritis at High-Risk of Gastrointestinal Adverse Events Dr. Lai Moon Sing
2005.426 Intracranial Magnesium Level and Energy Metabolism after Aneurismal Subarachnoid Haemorrhage: Effect of Magnesium Infusion Prof. Wong Kwok Chu George
2005.418 A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer Prof. Yeo Winnie
2005.416 A Phase II Study of Concurrent Cetuximab, Cisplatin and Radiotherapy in the Treatment of Advanced Nasopharyngeal Carcinoma Prof. Ma Buig Yue Brigette
2005.415 An Open Label, Randomized, Parallel Group, Multicentre, Phase III Study to Assess Efficacy, Safety and Tolerability of Gefitinib (IRESSA Prof. Mok SK Tony
2005.414 A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin Prof. CHAN Anthony
2005.409 Double-blind, Randomized, Parallel-group, Dose Ranging, Multi-center Study to Evaluate the Efficacy and Safety of 2.5, 10, 35 and 50mg AVE7688 Once Daily, Using 100mg Losartan-Potassium Once Daily As Calibrator, for 12 Months Treatment, In Patients with Mild to Moderate Hypertension Prof. Yu Cheuk Man
2005.408 A Phase II Study of Hormonal Therapy and Docetaxel and Prednisolone in Patients with Hormone-Treatment Na_ve Metastatic Prostate Adenocarcinoma Dr. Ng Chi Fai
2005.402 Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Prospective, Multi-Centre, Parallel-Group, Non-Inferiority Trial (RE-LY STUDY) Prof. Yu Cheuk Man
2005.400 Comparisons of Equiosmolar Doses of Mannitol 20% Versus Hypertonic Saline 7.5% Infusion in the Reduction of Brain Bulk During Elective Craniotomies for Supratentorial Brian Tumor Resection Prof. Chan TV Matthew
2005.398 Effect of Combined CYP2C19 and CYP2D6 Polymorphism On Fluoxetine Pharmacokinetics Prof. Chow S.S. Moses
2005.397 Combination of Aprepitant and Dexamethasone to Prevent Postoperative Nausea and Vomiting Prof. Chan TV Matthew
2005.394 INTEnsive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) A Randomized Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients with Stroke due to Acute Intracerebral Haemorrhage Prof. Wong Ka Sing Lawrence
2005.393 STROKe Observational Program in Asia (STROKOP-Asia) Prof. Wong Ka Sing Lawrence
2005.379 A Randomized, Single-Dose, Cross-Over, Bioavailability Study to Evaluate Propranolol HCI (DDC100105) Sublingual Tablet As Compared With Propranolol HCL (Inderal_) Immediate Release Oral Tablet in Healthy Volunteers Prof. Chow SS Moses
2005.378 Clinical Bioequivalence Study On Two Sulphasalazine Formulations Prof. Chow SS Moses
2005.377 Prospective Randomized Controlled Trial To Compare Ertapenem & Sulperazone in the Management of Acute Cholangitis Prof. Ng Kwok Wai Enders
2005.370 Pharmacokinetics of Single and Repeated Oral Administration of S 18886 30mg Daily in Chinese Healthy Male Volunteers Prof. Brian Tomlinson
2005.369 Randomized Phase II Study of the Combination of Oral Vinorelbine With Capecitabine Versus A Sequential Regimen of Oral Vinorelbine and Capecitabine Versus the Combination of Docetaxel and Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines Prof. Yeo Winnie
2005.368 A Randomized, Single-Dose, Open-Label, Two-Way Crossover Study to Investigate the Pharmacokinetics of HPD-333-A Transdermal System in Healthy Subjects Prof. Brian Tomlinson
2005.367 The Effect of Eplerenone Versus Placebo on Cardiovascular Mortality and Heart Failure Hospitalization in Subjects with NYHA Class II Chronic Systolic Heart Failure (EMPHASIS-HF) Prof. Yu Cheuk Man
2005.366 A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/ Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial Prof. YU Cheuk Man
2005.365 An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1mg in Patients with Type 2 Diabetes Mellitus (GALLEX 1) Prof. Chan CN Juliana
2005.364 Single Dose Aprepitant Prevent Postoperative Nausea and Vomiting Prof. Chan TV Matthew
2005.363 Second Generation Antihistamine to Prevent Postoperative Nausea and Vomiting Prof. Chan TV Matthew
2005.358 A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects Prof. Gin Tony
2005.347 A Randomized Comparison of Dexmedetomidine and Diazepam-Pethidine Sedation for Colonoscopy Prof. Chan TV Matthew
2005.341 A Phase I, Multi-Centre, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Local and Systemic Tolerability of the Therapeutic DNA Plasmid pdpSC18 Vaccine Administered by Particle Mediated Epidermal Delivery Using the PowderJect ND10 Delivery System in Subjects with Chronic Hepatitis B Infection Prof. Chan LY Henry
2005.340 SAINT II (Stroke Prof. Wong Ka Sing Lawrence

Page 243 of 254.